| Ms Cheri Kay Hutchins, CHERI HUTCHINS, CRNA | |
|
700 Eddie Hoffman Drive, Bethel, AK 99559 | |
| (907) 543-7979 | |
| (907) 543-6362 |
| Full Name | Ms Cheri Kay Hutchins |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 700 Eddie Hoffman Drive, Bethel, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285704155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 143 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cheri Kay Hutchins, CHERI HUTCHINS, CRNA Po Box 204, Haines, AK 99827-0204 Ph: (907) 766-2048 | Ms Cheri Kay Hutchins, CHERI HUTCHINS, CRNA 700 Eddie Hoffman Drive, Bethel, AK 99559 Ph: (907) 543-7979 |
News Archive
BioGenes GmbH, a supplier of GMP compliant immunoassay and antibody services, has developed and optimized the first ever fully validated ELISA protocol for Midkine detection in blood serum.
Democrats consider or profess their support for a Republican plan that would allow Americans to keep their canceled health insurance plans. In the meantime, fights continue to rage over the health law's navigators, and in political races.
In a new take on use of luminescent nanoparticles as cancer imaging probes, a team of investigators from several research institutes in Paris, France, has developed new metal-containing nanoparticles that emit light for several hours after they are initially excited.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of thousands of women each year in the United States alone.
A study published by Nature has defined the function of p110 alpha, the flag-ship molecule of the eight member PI3K family, which is one of the most frequently activated pathways in cancer. The function of p110 alpha in the body has eluded researchers for over a decade but a new approach to generating mouse models, has allowed investigators to solve the mystery and yield important information for planned clinical trials with PI3K inhibitors.
› Verified 7 days ago